Leprosy Mailing List – June 1, 2021
Ref.: (LML) WHO Goodwill Ambassador's Leprosy Bulletin NO. 103 MAY 2021
From: Takahiro Nanri, Tokyo, Japan
Dear Dr. Schreuder and Friends,
Warm greetings from Sasakawa Health Foundation/Sasakawa Leprosy (Hansen's Disease) Initiative in Tokyo.
We have issued WHO Goodwill Ambassador's Leprosy Bulletin NO. 103 MAY 2021 today. In this issue, we feature:
MESSAGE FROM THE AMBASSADOR
Thirty years ago, in 1991, the 44th World Health Assembly adopted a resolution to eliminate leprosy as a public health problem at the global level by the year 2000. Since then, most of the world's countries have attained elimination as it was then defined: reduction of prevalence to a level below one case per 10,000 population. Read More
VIEWPOINT
Reflections on 30 years of the elimination strategy
The resolution by the World Health Organization (WHO) to "eliminate leprosy as a public health problem by the year 2000," adopted by the World Health Assembly in 1991, was instrumental in changing the face of leprosy as we entered the 21st century. The elimination strategy involved worldwide implementation of multidrug therapy (MDT) and complementary strategies that evolved as more patients were cured. Read more
REPORT
Task Force on Criteria for Elimination of Leprosy (TFCEL) and Its Outcomes
The new WHO Global Leprosy Strategy 2021-2030 "Towards zero leprosy" has recently been published. Now that we have a tool in hand to prevent leprosy — post-exposure (chemo) prophylaxis (PEP) with single-dose rifampicin (SDR) — it is appropriate to set our sights on interrupting transmission of M. leprae and on achieving zero incidence of new cases of leprosy in endemic countries. Accordingly, the goal of the new Global Leprosy Strategy is "elimination of leprosy (defined as interruption of transmission/absence of disease)."Read more
LETTER
Seeking international recognition for Sungai Buloh
Ninety years ago in Selangor, Malaysia, a lush valley known as Sungai Buloh was transformed into a home for leprosy patients. Covering an area of 562 acres, the Valley of Hope, as it is sometimes called, was the largest leprosy settlement in the British Empire and the second largest in the world. Read more
COVID-19 relief efforts for India's self-settled leprosy colonies
The COVID-19 pandemic has left us in the face of an unprecedented crisis. The most severely impacted have been the poor and marginalized population, including persons affected by leprosy residing in self-settled leprosy colonies. In the wake of a country-wide lockdown last year, the priority of Sasakawa-India Leprosy Foundation (S-ILF) was to ensure food and necessary household supplies so that "no one should remain hungry" in the colonies. Read more
WISH LIST
Eduardo de Miguel Selma, Head of Fontilles International Projects Department, shares his list of wishes. Read more
ANNOUNCEMENT
Remembering Dr. P.K. Gopal
Dr. P.K. Gopal passed away on March 18, 2021. Born in Tamil Nadu, India, Dr. Gopal was diagnosed with leprosy at the age of 12. After being cured, he devoted his life to helping others affected by the disease. Read more
Establishment of rapid diagnostic method to detect rifampicin resistance
Sasakawa Health Foundation is supporting research being conducted by Koichi Suzuki, professor of medical technology at Teikyo University, and Kei Mikita, assistant professor of infectious disease medicine at Keio University School of Medicine, which aims to develop a rapid diagnostic method for detecting rifampicinresistant Mycobacterium leprae that can be easily performed anywhere without the need to transport specimens to a specialized laboratory and that can provide results on site by the following morning. Read more
INITIATIVE NEWS
VISION, MISSION, GOALS, STRATEGIES
We have updated our vision, mission, goals, and strategies and the graphic summary can be downloaded through our website. Read more
New website for Sasakawa Leprosy (Hansen's Disease) Initiative
The Sasakawa Leprosy (Hansen's Disease) Initiative has launched a new English language website. Read more
We hope that you would enjoy reading the latest Leprosy Bulletin.
Takahiro NANRI, Ph.D.
Executive Director, Sasakawa Health Foundation
*********************************************************
Sasakawa Leprosy (Hansen's Disease) Initiative
Sasakawa Health Foundation
Tel：81-3-6229-5377, Fax：81-33-6229-5388
email: hansen@shf.or.jp
visit our website at https://www.shf.or.jp
*********************************************************
LML - S Deepak, B Naafs, S Noto and P Schreuder
LML blog link: http://leprosymailinglist.
Contact: Dr Pieter Schreuder << editorlml@gmail.com
No comments:
Post a Comment